Autumn acquisition of nematodes by calves given a morantel sustained-release bolus the preceding spring

Reinfection with nematodes late in the grazing season was assessed in calves treated the preceding spring with a morantel sustained-release bolus (MSRB). During an initial 155-day grazing period, MSRB-treated calves (n = 15) grazed a pasture used the preceding year for identically treated calves (MSRB pasture). Control calves (n = 15) were not given anthelmintic treatment in the spring and grazed heavily contaminated herbage for the initial 155-day period (control pasture). At the end of the initial grazing period, 3 calves from each group were killed for parasite recovery and counting, with control calves found to harbor 9.2 times more nematodes, compared with the MSRB-treated calves. Nematode counts from tracers killed periodically during the initial grazing period were of similar proportions, reflecting the much greater nematode exposure experienced by the control calves, compared with the MSRB-treated calves. At the end of the initial grazing period, 10 calves (5/group) were placed on a common, contaminated pasture after all were treated twice with fenbendazole (10 mg/kg of body weight, 7 days apart) while on concrete. The second grazing period was for 29 days, followed by a 3-day confinement on concrete. Then, the calves were killed and necropsied. During the 29-day grazing period, the MSRB-treated calves maintained their weight advantage over the control calves, and significant differences in nematode egg counts were not found between the 2 groups of calves. At necropsy, the MSRB-treated calves harbored 27.9% fewer nematodes than did the controls, indicating that prior therapeutic and prophylactic anthelmintic activities of the MSRB did not predispose the animals to enhanced acquisition of nematodes after MSRB protection.     

Effect of the morantel sustained-release bolus, used during one grazing season, on the sensitivity of Ostertagia and Cooperia to morantel tartrate in calves

Infective 3rd-stage larvae of Ostertagia and Cooperia, obtained from the feces of nonmedicated and morantel sustained-release bolus (MSRB)-treated calves, were orally administered to 2 groups of parasite-free calves. After a 42-day maturation period, a therapeutic dose of morantel tartrate was administered to half of the calves from each group. All calves were necropsied 7 days after treatment. After comparing the nematode counts for the nonmedicated and morantel-treated calves of each group, morantel tartrate was demonstrated to be equally effective against the nonmedicated-derived and MSRB-derived nematode populations. The sensitivity of Ostertagia spp and Cooperia spp to morantel tartrate, therefore, was not diminished after use of the MSRB for a single grazing season.     

Some observations on the use of the morantel sustained-release bolus in first season-grazing calves on a Belgian dairy cattle farm

The efficacy of the morantel sustained-release bolus (MSRB) in controlling gastrointestinal parasites in first-season grazing calves was evaluated on a dairy cattle farm in Belgium. The calves grazed a pasture which had been used by bolus-treated animals in the three previous years. The effect of bolus administration was determined with respect to live weight gain, faecal egg shedding, herbage larval counts, serum pepsinogen levels and ELISA antibody titres. In spite of an incomplete reduction of faecal egg shedding during the first months of the grazing season, bolus administration resulted in the prevention of parasitic gastro-enteritis in the calves. A weight gain advantage of 35,2 kg of the bolus-treated animals over the controls was noted already at two months after turnout. This weight gain advantage was maintained until housing. The usefulness of serum pepsinogen values and ELISA antibody titres as parameters in prevention experiments is stressed. Both serological parameters gave more information concerning infection level than did the faecal egg output and the herbage larval counts.     

Grazing study in Ireland using the morantel sustained release bolus for controlling nematodiasis in calves

The morantel sustained release bolus was administered at turnout to first-season grazing calves in order to assess its efficacy in the seasonal control of infection by nematode parasites in Ireland. The pastures grazed by control calves showed a marked increase in gastrointestinal trichostrongylid infective larvae by September, while numbers of infective larvae on pasture grazed by bolus-treated calves remained at a low level throughout the grazing season. In consequence, the controls showed significantly higher worm egg counts in late season and significantly higher worm burdens (mainly Ostertagia spp) at necropsy carried out in November on representative number of principal animals selected from each group. These reduced worm burdens were attributed to the suppression of egg output during the early part of the season as a result of treatment with the morantel sustained release bolus at turnout in the spring. Pasture contamination with Dictyocaulus viviparus larvae was present on all treatment pastures. The bolus-treated calves however were subjected to an increase in D. viviparus infection which occurred on their pasture in late season after the active life of the bolus had expired. It was concluded that bolus treatment delayed (rather than prevented) the buildup of D. viviparus infection on the pasture by 60-90 days.     

Efficacy of a morantel sustained-release bolus for the control of gastrointestinal nematodes in Florida dairy heifers

The effectiveness of a morantel sustained-release bolus (MSRB) in controlling gastrointestinal nematode infections was determined in 70 Holstein heifer calves with no prior grazing experience. Calves were allotted to 2 treatment groups and were maintained in Florida during the grazing season on divided pastures of equal area. One MSRB was administered to each calf in 1 group at the time of turnout onto spring pasture, whereas calves in the other group remained as nonmedicated controls. By the end of the grazing season, treatment resulted in significantly (P less than 0.05) lower worm burdens and significantly improved weight gains. The MSRB-treated calves were able to reach breeding weight 2 to 4 weeks earlier than did nonmedicated calves.     

Efficacy of the morantel sustained release trilaminate matrix against gastrointestinal nematodes in beef calves

The effectiveness of the morantel sustained release trilaminate (MSRT) in controlling gastrointestinal nematodes through a grazing season was evaluated using 60 yearling beef stocker calves randomly divided into 2 groups of 30 animals each. In April 1985, the calves comprising the treatment group each received an MSRT designed to release morantel tartrate continuously for 90 days while those of the control group remained unmedicated. All animals were weighed and samples of rectal feces were taken at 14-day intervals, beginning on Day 0, until trial termination (Day 168). At trial termination, 10 control and 10 treated calves were necropsied for recovery of gastrointestinal nematodes. Three sets of parasite-na?ve tracer calves were utilized to evaluate the initial, interim and final levels of pasture contamination by nematode larvae. Overall, the use of the MSRT resulted in a 75.5% reduction (P less than 0.001) in output of nematode eggs from the principals, an 81.8% reduction (P less than 0.001) in numbers of gastrointestinal nematodes in principals (at trial termination), and a 96.9% reduction (P less than 0.05) of pasture larval nematode contamination (as indirectly indicated by parasite burdens in tracer calves). The mean weight advantage of treated calves was 16.6 kg per head (P less than 0.001).     

Efficacy of morantel sustained-release bolus in control of gastrointestinal nematodes of weaned calves during the autumn-winter grazing season

A 168-day study was conducted to evaluate the efficacy of morantel tartrate sustained-release bolus (MSRB) in controlling gastrointestinal parasitism in weaned calves during autumn-winter grazing in the temperature climate of southern United States. Sixty-two weanling Angus heifers were used to assess treatment differences. Six sentinel heifers were necropsied to assess pretrial gastrointestinal worm counts. The remaining 56 heifers were assigned to 4 groups of 14 heifers each and were placed on four 4.86-hectare dormant Bermuda grass pastures (1 group/pasture) that had been no-till interseeded with cereal rye in early October. Heifers in 2 groups were given 1 MSRB in early November; the other 2 groups served as nonmedicated controls. Three heifers (principals) from each of the 4 groups were necropsied on posttreatment days 57, 112, and 168 (end of study) for total worm recovery. Eight 5-month-old tracer steers, raised worm-free from birth, grazed the 4 pastures (2/pastures) for the first 21 days of the study and then were kept in drylot for 21 days before being necropsied. Level of larval contamination of pastures grazed by control and MSRB-treated heifers were comparable, because the mean number of nematodes recovered from tracer steers grazing the control and MSRB pastures were 47,449 and 53,835, respectively. At 28 days after treatment, MSRB-treated heifers had lower (P less than 0.05) mean egg counts/g of feces than did control heifers (280 vs 13).(ABSTRACT TRUNCATED AT 250 WORDS)     

A morantel sustained-release bolus for the control of gastro-intestinal nematodes in grazing calves

Prophylactic (summer) and/or therapeutic (autumn) administrations of an intra-ruminal sustained-release bolus (MSRB) containing morantel tartrate were compared for the control of gastro-intestinal nematodes in grazing dairy calves over an 8-month period (December to August). The MSRB was designed to release morantel tartrate at 150 mg/day for 90 days.

Treated and untreated groups of calves grazed separate replicated pastures. Both groups of calves receiving the MSRB at the beginning of summer showed a significant mean liveweight advantage (17.7 kg and 20.7 kg for the summer and summer/autumn treated groups, respectively) at the end of the trial period, when compared with untreated calves. The liveweight advantage of calves receiving the MSRB in autumn only (6.5 kg) was not significantly different from that of the controls.

Both the summer and autumn administrations of the MSRB prevented the accumulation of Pre-Type II burdens of Ostertagia spp.

Retention rates of the MSRB were high and chemical analysis of faecal samples indicated a fairly constant release of the anthelmintic over the predicted 90-day period.

The results indicate that the MSRB is potentially useful for the control of gastro-intestinal nematodes, and particularly for the production of ’safe’ pasture. The MSRB could provide an effective alternative to integrated control based primarily on grazing management.     

Controlled field trial on the anthelmintic effectiveness of the morantel sustained-release bolus in grazing calves

The direct and indirect anthelmintic efficacies of the morantel sustained-release bolus given to calves were assessed in a 154-day controlled field trial. A permanent calf pasture (divided into 2 lots) and naturally parasitized calves were used. The medicated calves were given the bolus at the time they were placed on the pastures. Control calves did not receive anthelmintic therapy. The effectiveness of the bolus to control parasitic gastroenteritis was determined by monitoring various parasitologic determinants. The treated calves had significantly (P less than 0.01) reduced numbers of fecal nematode eggs for every posttreatment sampling period when compared with the control calves. Tracer calves, used periodically during the study to indicate pasture larval infectivities, had equivalent worm burdens at the beginning of the trial (treated vs control pasture). Tracer calves, added later in the study to the lot with treated calves, harbored 83% to 94% fewer nematodes than did their counterparts in the lot with the controls. Plasma pepsinogen concentrations, reflective of abomasal worm burden size and/or activity, were significantly higher (P less than 0.01) in the control than in the treated calves from day 54 until trial termination. At trial termination, the treated calves weighed an average of 27.8 kg more and harbored 80.9% fewer nematodes than the control calves. The morantel sustained-release bolus is an anthelmintic delivery device that has therapeutic and prophylactic antinematode activities. To achieve its optimum performance, the bolus must be used so that the epizootiologic patterns of the predominate parasitic nematodes are effectively disrupted. Generally, internal nematode parasitisms in the calf flourish during the animal's first springtime grazing period.(ABSTRACT TRUNCATED AT 250 WORDS)     

The use of the morantel sustained release bolus under special farm practices (deprime system) in France

The efficacy of the morantel sustained release bolus in controlling gastrointestinal and lungworm parasites when used in first-season grazing animals which followed older animals onto spring pasture (deprime system) was assessed in three trials conducted in Normandy, France. In each trial first-season grazing calves were equally allocated onto two separate but equivalent paddocks where they remained throughout the grazing season. A morantel sustained release bolus was administered to one group of animals at turnout, the other group remained as controls. The effect of the treatment on contamination of pasture (herbage larval counts and tracer worm counts), on faecal worm egg and lungworm larval counts, and on weight gain performance of the principal animals was assessed. In all three trials, worm egg output in the bolus-treated animals was substantially lower throughout the season compared with the control animals. Worm burdens of tracer calves grazing pastures of the treated cattle were also reduced compared with tracer calves grazing control pastures. Clinical parasitic gastroenteritis occurred in the control animals but not in the bolus-treated animals in one trial. Overall the bolus-treated animals outperformed the controls by a mean weight gain advantage of 10.5 kg (P less than 0.01).     

A comparison of the efficacy of four different long-acting boluses to prevent infections with Dictyocaulus viviparus in calves

A field study of calves in their first grazing season tested the efficacy of four long-acting devices--a morantel sustained-release bolus, a levamisole sustained-release bolus, an oxfendazole interval bolus, and an albendazole interval bolus--against Dictyocaulus viviparus. The pasture had been previously contaminated by four calves orally inoculated with infective lungworm larvae. The calves were grazed together with four bolus-treated groups, each comprising four calves. Lungworm infection became patent in the experimentally inoculated calves between 22 and 26 days. Infection in the bolus-treated groups became patent after 54 days. The morantel bolus group excreted the most larvae, followed by the albendazole bolus group, and the levamisole bolus group. The oxfendazole bolus group excreted by far the least larvae. Eosinophil curves and ELISA titres showed that treated groups had essentially the same course of infection. The heavy infection to which the treated calves were exposed produced complete immunity in all groups. Challenge infection of 10,000 larvae at housing did not change any of the test parameters. Post-mortem examination showed only one positive calf with few worms. We concluded that when pastures are heavily infested with lungworm larvae, all boluses prevent severe clinical signs and allow build up of solid immunity, although none completely prevent excretion of larvae.     

Use of the sustained-release morantel bolus in stocker calves in southern United States

Two groups of 21 mixed-breed heifers were wintered on separate permanent pastures. Each heifer from one group was administered a sustained-release morantel bolus on October 7 (day 0), and the other group remained as untreated controls. Body weights were determined and fecal samples were taken at 28-day intervals. At the onset of the trail and at every 56 days, 6 heifers were removed from each group for slaughter to determine the developmental stages and the number of gastrointestinal nematodes. In addition, 3 tracer calves that were free of gastrointestinal nematodes were released on each pasture for 28 days at the beginning of the trail and after the last experimental-group calves had been removed. The 6 calves slaughtered on day 0 of the trail had a mean of 5,544 gastrointestinal nematodes. Tracer calves released on day 0 and removed on day 28 of the trial acquired 31,143 and 30,530 gastrointestinal nematodes from the pastures containing the treated and control heifers, respectively. Throughout the trial, the number of nematodes in the control calves increased at each sampling date (mean, 126,168 worms), whereas the mean number of worms in the treated heifers was 45,458. Tracer calves placed in the pastures after the 168-day trail acquired significantly more worms (9,632 vs 2,899; P less than 0.05) from grazing the pastures with control heifers than from grazing the pastures with treated heifers. Counts of eggs per gram of feces were significantly different (P less than 0.01) between the 2 groups from day 28 through day 112.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of ivermectin delivered from a sustained-release bolus on the productivity of beef cattle in Oregon

The effect of ivermectin delivered from a sustained-release bolus (I-SRB) on the weight gain of beef cattle through a grazing season was evaluated using 20 yearling beef steer calves randomly divided into two groups of ten animals each. Calves in the control group each received a placebo bolus, while those in the treatment group each received an I-SRB designed to release 12 mg ivermectin day-1 for approximately 90 days. All animals were weighted and samples of feces were collected from the rectum at monthly intervals, beginning on Day 0, until trial termination (Day 148). Pasture larval counts were also conducted on herbage collected on each sampling date. On Day 119, two control and two treated calves were removed from pasture, housed in isolation for 3 weeks, then necropsied for recovery of gastrointestinal nematodes. Three sets of parasite-naive tracer calves were utilized to evaluate the initial, interim and final levels of pasture contamination by nematode larvae. A fourth set was used to evaluate the level of pasture contamination the following spring. The use of the I-SRB resulted in a greater than 99% reduction in fecal egg counts of trichostrongyles and numbers of gastrointestinal nematodes in the treated principals, as well as an average daily gain advantage of 0.114 kg over the 148 day period. A 67-98% reduction in pasture larval nematode contamination occurred on pastures grazed by the treated animals, as indicated by the parasite burden in tracer calves and pasture larval counts. The treatment effect was eventually lost by the following spring since tracer calves on the treated pasture had only 33% fewer nematodes than those on the control pasture.     

Effectiveness of a slow-release, morantel tartrate anthelmintic bolus for controlling parasitic gastroenteritis in replacement dairy heifers

Two experiments were done to evaluate the effectiveness of a slow-release, morantel tartrate, anthelmintic bolus for controlling parasitic gastroenteritis in replacement dairy heifers. In experiment 1, good control of nematode contamination of pasture was indicated by lower worm burdens in tracer calves that grazed with 15 heifers treated orally with a single bolus and by significantly decreased numbers of nematode eggs in the feces of the 15 treated heifers, as compared with numbers of eggs in the feces of 15 nontreated control calves. Significant differences in weight gain were not seen between treated and nontreated heifers, probably due to low amounts of larval exposure, the small number of heifers evaluated, and parasitic resistance in the heifers, which may have developed as a result of prestudy exposure to contaminated pasture. In experiment 2, done 1 year after the 1st experiment, using the same pastures that were used in experiment 1, young heifers were used. Many of the heifers were parasite naive at the beginning of the experiment (ie, nematode eggs were not found before the experiment). Treatment with the bolus was effective in controlling parasitic gastroenteritis in the heifers and in controlling nematode contamination of pasture. Compared with nontreated heifers, treated heifers had significantly higher cumulative weight gains, a significant decrease in plasma pepsinogen concentrations, and a significant decrease in worm egg excretion. The number of worms acquired by tracer calves that were grazed with treated heifers was significantly less than for tracer calves that were grazed with nontreated heifers.     

Efficacy of morantel sustained release bolus against gastrointestinal nematodes in first season grazing Holstein calves

The efficacy of the morantel sustained release bolus (MSRB) in reducing gastrointestinal parasitism in first season grazing calves was evaluated during the summer--autumn grazing seasons of 1982 and 1983 in western Oregon. Each of 38 calves (1982) and 40 calves (1983) were randomly assigned to either control or treatment groups which were given MSRB on the day of turnout onto pasture. Mean worm burdens from tracer calves grazed with treated animals in 1982 and 1983 showed overall reductions of 86.4% (P greater than 0.05) and 84.3% (P less than 0.01), respectively, compared to tracers grazed with controls. Ostertagia ostertagi, Cooperia oncophora and Nematodirus helvetianus were the primary nematodes collected at necropsy. Twelve full-season 1982 tracer animals (6 treated and 6 control) indicated an 88.1% (P less than 0.05) overall reduction in mean worm burdens. Mean fecal worm egg per gram (EPG) counts of treated animals reflected a reduction of 69% (P less than 0.05) in 1982 and 90% (P less than 0.05) in 1983. Autumn inhibition of O. ostertagi was observed. In the 1982 trial the control animals showed a slight mean weight gain advantage over the treated group from Day 84 until Day 160 (trial termination) when the mean difference was 7.9 kg. The final mean weight gain advantage of treated animals in 1983 was 13.5 kg (P less than 0.05). These trials demonstrated that the MSRB was an effective anthelmintic for reducing gastrointestinal parasitism in grazing calves and for decreasing pasture larval contamination.     

Efficacy of the morantel sustained-release bolus in grazing cattle in North America

The efficacy of using a bolus containing morantel in a sustained-release preparation for controlling naturally acquired gastrointestinal parasitic infections in weaned calves and yearling cattle was investigated during the 1982 grazing season at selected sites in the United States and Canada. According to a common trial design under various climatic and management conditions, 10 field trials were conducted with the bolus. At the time of spring turnout, a bolus was administered to each calf or yearling in the treated group. Then, treated and control cattle grazed separate but equal areas of divided pasture(s). The epidemiologic pattern of parasitic gastroenteritis in control animals and the effect of treatment on this pattern was determined in each trial. Safety and practicality of use of the bolus also were established. When compared with untreated cattle (control), those given the bolus deposited significantly (P less than 0.05) fewer worm eggs (89% reduction) during the first 90 days of the grazing season, as well as significantly fewer (P less than 0.05) worm eggs (84% reduction) during the entire grazing season. Consequently, during the second half of the grazing season, larval populations on treated pastures remained significantly (P less than 0.05) lower (66% reduction), compared with numbers of larvae found on control pastures. For pastures grazed by treated and control cattle at trial initiation, mean worm counts recovered from tracer calves were equal, indicating comparable pasture contamination at the beginning of the grazing season.(ABSTRACT TRUNCATED AT 250 WORDS)     

Evaluation of the morantel sustained release bolus in cows and calves

The efficacy of the morantel sustained release bolus (MSRB) in controlling gastrointestinal parasitism in beef cattle was assessed during the 1982 spring-autumn grazing season. Forty-eight cows and their calves were allotted to three equal groups. One group (T-1) served as a nonmedicated control group. One MSRB was administered to each calf of the T-2 group, and to each cow and calf of the T-3 group at the beginning of the study. The efficacy of the bolus was assessed by comparison of weight gain performance and parasitological data (fecal worm egg counts, herbage larval counts, worm counts from tracer and principal trial calves, and plasma pepsinogen level determinations). Though not statistically significant, treated calves from Group T-2 had a numerical mean weight gain advantage of 2.6 kg, and those from Group T-3 of 4.7 kg, over control calves. Average daily gains (ADG) for the three groups of calves were 0.69, 0.72, and 0.73 kg, respectively. Untreated cows from Group T-2 and treated cows from Group T-3 outperformed the control cows by 12.3 and 7.5 kg, respectively. Fecal worm egg counts from both groups of treated calves were significantly (P less than 0.01) lower than counts from control calves during the entire 169-day trial; notably, egg counts were reduced by 99% 28 days after MSRB administration to both groups of calves. There were no significant differences in the number of eggs counted from the three groups of cows, probably because of the very low numbers of eggs encountered. Mean total worm burdens of principal calves (six per group) necropsied at trial termination indicated a 91% (P less than 0.01) reduction in Group T-2 and an 87% reduction (P less than 0.01) in Group T-3. Worm-free tracer calves were introduced onto pastures every 28 days to monitor availability of infective larvae. The mean number of worms recovered at necropsy from tracer calves that grazed with control cattle increased as the season progressed. However, the numbers of parasites recovered each month from mid-August through mid-October from tracers that grazed pastures with treated cattle were lower (P less than 0.05) than those levels displayed at trial initiation. In addition, the mean numbers of worms from treated group tracers were lower than from the controls for each necropsy period.(ABSTRACT TRUNCATED AT 400 WORDS)     

A comparison of the morantel sustained-release bolus with conventional drenching for the control of gastro-intestinal nematodes in grazing calves

A comparison was made of the parasitological and production responses to the prophylactic (summer) and combined prophylactic and therapeutic (summer/autumn) administrations of the morantel intraruminal, sustained-release bolus (MSRB) with responses to conventional drenching in grazing dairy calves over an 8-month period. The MSRB was designed to release morantel tartrate at 150 mg/day for 90 days. In two concurrent trials, groups of calves grazed separate replicated pastures. In Trial 1, the combined summer (December) and autumn (March) administration of the MSRB was compared with a programme of six drenches (oxfendazole at 4.53 mg/kg) at 28-day intervals from December to May. In Trial 2, the summer administration of the MSRB was compared with a programme of three autumn drenches (oxfendazole) at 28-day intervals from March to May. There were no significant between-treatment differences in mean liveweight gain in either trial. In both trials, the low numbers of eggs passed by the MSRB-treated animals during summer (maximum mean 62 eggs per gram of faeces) were sufficiently high to produce a modest autumn larval peak (maximum 1990 larvae/kg herbage). In Trial 2, the summer use of the MSRB resulted in an 83% reduction in peak larval availability compared with that on pastures grazed by untreated calves during summer. Only the 6-drench regimen (Trial 1) prevented the accumulation of appreciable worm burdens of early 4th stage Ostertagia spp.     

The use of a morantel sustained release bolus in the seasonal control of parasitic gastroenteritis in second-season cattle

The efficacy of a morantel sustained release bolus was evaluated during the 1980 summer grazing season in 216 yearling, second-season cattle in nine trials in West Germany. In five trials individual farms were used, in which medicated and control groups could be grazed on adjacent pastures. In four additional trials medicated and control groups were maintained on separate farms where the sites and management practice were matched as far as possible. Faecal worm egg counts, herbage larval counts and weight gain were monitored at regular intervals throughout the season. The faecal output of gastrointestinal nematode eggs was reduced by 55.8 percent in the medicated animals during the period from May to early August, while worm egg counts were equal to that of the control animals during the later part of the season. Herbage larval counts were similar on pastures grazed by medicated and nonmedicated cattle. In the five trials where individual farms were used the average daily weight gains over the entire grazing period were 900 (+/- 222) g/animal/day in the medicated group compared with 826 (+/- 263) g/animal in the nonmedicated cattle, a non-significant advantage. No advantage for the treated over the control groups was detected in the additional 4 trials but this was attributed largely to the difficulty in obtaining comparable groups of animals in comparable grazing conditions in "matching" farms, leading to inter-farm variation.     

A field study of the ivermectin sustained-release bolus in the seasonal control of gastrointestinal nematode parasitism in first season grazing calves

The effect of an ivermectin sustained-release bolus (I-SRB) on the epidemiology of nematode parasites and on calf productivity was evaluated in a field trial under Northwestern European conditions. Twenty parasite-naive female Friesian calves (principals) aged 5–9 months were used together with six male Friesian tracer calves. Principal calves were allocated by restricted randomization on day 0 body weight to either an untreated control group or a group given one I-SRB, designed to deliver 12 mg ivermectin per day for 135 days, orally on day 0. Each group was grazed on adjacent paddocks, naturally contaminated with parasitic nematode larvae, from 13 May 1991 (day 0) until housing on 30 September (day 140). Body weights of principal calves were recorded and individual blood and faecal samples taken at regular intervals throughout the trial. Pasture nematode contamination was monitored by larval counts on herbage and by worm counts of tracer calves grazed on each paddock from day 126 to day 140. Nematode contamination levels on the control paddock did not rise until the end of the grazing season, as a result of a mid-summer drought period. The period of exposure to a high larval challenge was too short to provoke body weight losses and clinical parasitic gastroenteritis in control calves. Use of the I-SRB resulted in zero faecal egg counts of trichostrongyles during the whole pasture season, thereby preventing a build-up of parasitic gastrointestinal nematodes on pasture. During the second grazing season no signs of parasitic gastroenteritis were detected in any animal, but an outbreak of parasitic bronchitis (PB) was observed in both experimental groups, indicating that PB can occur in older cattle regardless of the control measures taken to prevent clinical parasitism during the first grazing season.